NasdaqGS - Nasdaq Real Time Price USD
Rallybio Corporation (RLYB)
0.3519
+0.0049
+(1.41%)
As of 3:15:40 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 3 |
| Avg. Estimate | -0.25 | -0.19 | -0.85 | -1.34 |
| Low Estimate | -0.26 | -0.21 | -0.91 | -2.27 |
| High Estimate | -0.23 | -0.17 | -0.78 | -0.64 |
| Year Ago EPS | -0.37 | -0.26 | -1.33 | -0.85 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 2 | 3 |
| Avg. Estimate | -- | -- | 200k | -- |
| Low Estimate | -- | -- | 200k | -- |
| High Estimate | -- | -- | 200k | -- |
| Year Ago Sales | 299k | 299k | 636k | 200k |
| Sales Growth (year/est) | -100.00% | -100.00% | -68.55% | -100.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.36 | -0.34 | -0.3 | -0.28 |
| EPS Actual | -0.37 | -0.26 | -0.25 | -0.21 |
| Difference | -0.01 | 0.08 | 0.05 | 0.07 |
| Surprise % | -3.39% | 23.10% | 15.73% | 26.32% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.25 | -0.19 | -0.85 | -1.34 |
| 7 Days Ago | -0.27 | -0.23 | -1.48 | -1.66 |
| 30 Days Ago | -0.26 | -0.23 | -1.35 | -1.66 |
| 60 Days Ago | -0.29 | -0.29 | -1.15 | -1.54 |
| 90 Days Ago | -0.3 | -0.32 | -1.41 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | -- |
| Up Last 30 Days | 1 | 1 | 2 | -- |
| Down Last 7 Days | 1 | -- | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RLYB | 33.78% | 26.92% | 36.47% | -58.58% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 4/15/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 4/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/17/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/3/2024 |
Related Tickers
TYRA Tyra Biosciences, Inc.
9.98
+3.10%
VIGL Vigil Neuroscience, Inc.
2.4862
-0.15%
ACRV Acrivon Therapeutics, Inc.
1.2350
+4.66%
PEPG PepGen Inc.
1.5350
+3.02%
GLUE Monte Rosa Therapeutics, Inc.
4.1150
+0.12%
CGEM Cullinan Therapeutics, Inc.
7.88
+2.20%
IMRX Immuneering Corporation
1.5100
-0.66%
DSGN Design Therapeutics, Inc.
3.6300
+2.83%
PULM Pulmatrix, Inc.
6.44
-0.31%
OVID Ovid Therapeutics Inc.
0.2883
-4.26%